BV Financial, Inc. filings document the bank holding company's public-company reporting for BayVanguard Bank, including Form 8-K disclosures of operating results, balance-sheet trends, stock repurchase authorizations, executive departures and related compensation arrangements, and changes in the independent registered public accounting firm.
Proxy and meeting filings describe director elections, auditor ratification, stockholder voting results, board and audit committee matters, and governance procedures. The filings also identify BVFL common stock, its Nasdaq listing, and disclosure topics tied to deposits, loans, securities portfolios, borrowings, asset quality, credit-loss allowances, and capital management.
BV Financial, Inc. reported mixed results for the quarter ended June 30, 2025. Total assets stood at $908.3 million, slightly below $911.8 million at year-end 2024. Total loans increased to $751.6 million from $737.8 million, and deposits rose to $658.9 million from $651.5 million, reflecting continued core lending and deposit growth. Cash and cash equivalents declined to $56.3 million from $70.5 million.
Net interest income was $9.156 million for the quarter, up modestly from $8.909 million a year earlier. Net income for the quarter was $2.861 million ($0.29 basic and diluted EPS), down from $3.399 million a year ago; year-to-date net income was $4.960 million versus $5.973 million prior year. Provision for credit losses reversed to an expense of $0.178 million for the quarter compared with a $0.111 million recovery a year earlier, and total allowance for credit losses was $9.159 million at June 30, 2025. Noninterest expense increased to $5.755 million, driven in part by higher compensation and stock-based compensation recognized in the period.
BV Financial, Inc. (BVFL) – Form 4 filing dated 07/08/2025. Director William B. Crompton III reported one insider transaction on 07/07/2025. Using transaction code G (gift), he disposed of 500 common shares held indirectly as trustee for a trust at $0 per share. Following the gift, the trust retains 10,510 shares. Crompton’s aggregate beneficial ownership now stands at 56,489 common shares (18,500 direct; 10,510 trust; 4,747 Roth IRA; 22,732 IRA).
In addition, he holds 36,746 stock options with a $14.25 exercise price, expiring 09/06/2034 and vesting 25% annually beginning 09/06/2025. No other non-derivative or derivative transactions were reported. The filing is routine and does not indicate any change in Crompton’s board status or company outlook.